AmplifyBio Raises $50M in Growth

AmplifyBio has successfully raised $50M in a Growth at a $280M valuation led by Vitrian, Safar Partners.

Company Overview

AmplifyBio is a Biotech company headquartered in New Albany, OH, founded in 2020 with 400+ employees.

Drug development company providing preclinical and clinical services

Fundraising Details

Amount Raised: $50M
Round Type: Growth
Valuation: $280M
Date: 2024-11-07
Investors: Vitrian, Safar Partners

About AmplifyBio

Drug development company providing preclinical and clinical services The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: New Albany, OH
Founded: 2020
Team Size: 400+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in AmplifyBio's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. AmplifyBio's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $280M valuation marks an important milestone for AmplifyBio, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, AmplifyBio is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-11-07. For more information about AmplifyBio, visit their headquarters at New Albany, OH.